Maabarot Products

Company Overview

Snapshot

Founded in January 1963, Maabarot Products operates with 51–200 employees. The company has engaged in multiple strategic acquisitions, including Laboratoria Natury in January 2011, expanding its portfolio in nutritional supplements and food products.

Business overview

Maabarot Products develops and manufactures a diverse range of nutritional supplements and food products for both human and animal consumption. The company's portfolio includes brands such as Anlit and Biopet, serving global markets within the Agriculture & Food Technologies sector.

Strategic signal

In October 2018, Maabarot Products submitted a bid for Teva's North Israel Facility, signaling a strategic interest in expanding its manufacturing capabilities or market presence within the region. This move indicates the company's proactive approach to growth and operational scaling within the food and nutrition industry.

Company Intelligence Q&A

When did Maabarot Products acquire Anlit?

Maabarot Products acquired Anlit in June 2008, integrating the company's offerings into its portfolio of nutritional products.

What was a significant strategic investment made by Maabarot Products?

In June 2018, Maabarot Products invested €4M in equity funding into Algaia, a French seaweed company, demonstrating a strategic interest in novel ingredients and expanding its product base.

When did Maabarot Products acquire Laboratoria Natury?

Maabarot Products acquired Laboratoria Natury in January 2011, expanding its presence in the nutritional supplements market.

What was a key divestment by Maabarot Products related to Materna?

In February 2017, Maabarot Products sold its remaining 49% stake in Materna to its partner Osem-Nestle, completing a divestment process that began in 2008.

What was Maabarot Products' activity regarding Teva's facility?

In October 2018, Maabarot Products submitted a bid for Teva's North Israel Facility, indicating potential expansion or diversification plans.